Malin Corporation

Malin Corporation Market capitalization

The The market capitalization of Malin Corporation (MLC.IR) as of Nov 10, 2026 is 33.15 M EUR. In the previous year, The market capitalization was 33.15 M EUR — a change of 0.00% (lower).

Market capitalization

33.15 MEUR

YoY

0.00%

Last updated:

In 2024, Malin Corporation's market cap stood at 33.15 M EUR, a 0.00% increase from the 33.15 M EUR market cap in the previous year.

The Malin Corporation Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2017
33.15 M EUR
Jan 1, 2018
33.15 M EUR
Jan 1, 2019
33.15 M EUR
Jan 1, 2020
33.15 M EUR
Jan 1, 2021
33.15 M EUR
Jan 1, 2022
33.15 M EUR
Jan 1, 2023
33.15 M EUR
Jan 1, 2024
33.15 M EUR
The Malin Corporation Market capitalization history
YEARMarket capitalizationYoY
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR0.00%
33.15 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Malin Corporation Stock analysis

What does Malin Corporation do? Malin Corporation PLC is an Irish company that was founded in 2014. The company is a subsidiary of Elan, a company specialized in pharmaceutical development. Malin has focused its business model on identifying, supporting, and scaling startup companies. The company supports and invests in startups in the biopharmaceutical industry that focus on new and innovative therapies. Malin offers help and advice to its portfolio companies in product development and business organization. The company has invested in various areas of the biopharmaceutical industry. For example, it has supported YumaTherapeutics, a company focused on the discovery and development of novel therapeutics for infectious diseases. Malin has also provided financial support to Seres Therapeutics, which has built a pipeline of therapeutics targeting the microbiome, the collection of microorganisms living in the gut. Malin has invested in Inivata, a company specialized in the development of cancer diagnostics. Furthermore, Malin has various other companies in its investment pipeline that deal with a variety of therapeutic possibilities. This includes therapies for genetic diseases and inherited metabolic disorders, as well as applications of gene therapy and immunotherapy. Malin Corporation PLC has also developed its own products and partnerships. One of these partnerships is with Novaerus, another Irish company specialized in the development of air purification systems. Novaerus systems use a plasma-based ion system to destroy bacteria, viruses, and fungi in the air, thus preventing infections. Malin is also involved in research collaborations. One collaboration is with University College Dublin, where Malin provides financial support for research on biopharmaceutical processes. The history of Malin Corporation PLC is characterized by a strong commitment to supporting innovative companies in the biopharmaceutical industry. The company aims to promote the growth and development of startups, offering not only financial support but also advice and expertise. Malin has diversified its investments in various areas of the biopharmaceutical industry and focuses on promoting products that improve people's health and well-being. The company has also developed its own products and partnerships to bring new technologies and therapies to the market. Overall, Malin Corporation PLC is a company specialized in supporting and promoting startups in the biopharmaceutical industry. The company is committed to developing products and therapies that have the potential to improve and prolong people's lives. Malin Corporation is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Malin Corporation's Market Capitalization

Malin Corporation's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Malin Corporation's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Malin Corporation's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Malin Corporation’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Malin Corporation stock

The market capitalization of Malin Corporation is 33.15 M EUR in 2024.

The market capitalization of Malin Corporation changed from 33.15 M EUR to 33.15 M EUR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Malin Corporation since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's EUR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' EUR varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Malin Corporation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Malin Corporation

All Key Metrics — Malin Corporation